Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Anavex's financial health is stable with cash runway into 2028, but rising expenses are expected. Click here to find out why ...

Explore our new AAV Titer ELISA and AAV Antibody Assay Kits, designed for exceptional specificity, sensitivity, and accuracy ...

A recent study published in the Harm Reduction Journal documents the arrival of xylazine to the San Diego-Tijuana border ...

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted ...

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted neuroanatomica ...

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing ...

JPMorgan keeps an Overweight rating and $80 price target on Viking Therapeutics (VKTX) after the company announced that it ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

Some people get confused by the terminology, the doctors noted. “I think there’s a little bit of a misconception, as some people say ‘I’m microdosing’ when they’re just on the starting doses or don’t ...

Metsera Announces Positive Topline Phase 2a Clinical Data for its Ultra-Long Acting GLP-1 Receptor Agonist, MET-097i ...